There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
[3aS-[2E,3aα,4α(1E,3R*),5β,6aα]]-5-[4-(3-Cyclopentyl-3-hydroxy-1-propenyl)hexahydro-5-hydroxy-2(1H)-pentalenylidene]pentanoic Acid-d4; (5E)-5-[(3aS,4R,5R,6aS)-4-[(1E,3S)-3-Cyclopentyl-3-hydroxy-1-propenyl]hexahydro-5-hydroxy-2(1H)-pentalenylidene]pentanoic Acid-d4; ONO 41483-d4; OP 41483-d4;
References
Matsumoto, K., et al.: J. Biochem., 117, 458 (1995);
Synonyms
[3aS-[2E,3aα,4α(1E,3R*),5β,6aα]]-5-[4-(3-Cyclopentyl-3-hydroxy-1-propenyl)hexahydro-5-hydroxy-2(1H)-pentalenylidene]pentanoic Acid-d4; (5E)-5-[(3aS,4R,5R,6aS)-4-[(1E,3S)-3-Cyclopentyl-3-hydroxy-1-propenyl]hexahydro-5-hydroxy-2(1H)-pentalenylidene]pentanoic Acid-d4; ONO 41483-d4; OP 41483-d4;
Application Notes
Ataprost-d4 is deuterium labelled form of Ataprost (A790205), which is a prostaglandin hepatocyte growth factor gene expression inducer and tissue regeneration mediator.
Hazard Compound
Refer MSDS for complete information.
Overview
Ataprost-d4 is deuterium labelled form of Ataprost (A790205), which is a prostaglandin hepatocyte growth factor gene expression inducer and tissue regeneration mediator.
